tradingkey.logo
tradingkey.logo
Search

Outset Medical Inc

OM
Add to Watchlist
4.570USD
-0.180-3.79%
Close 07-31 16:00ETQuotes delayed by 15 min
83.03MMarket Cap
LossP/E TTM

OM Income Statement

You can find the annual or quarterly income statement of Outset Medical Inc here for insights into the performance and operational efficiency of Outset Medical Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
Total revenue
-6.35%27.86M
-2.01%28.87M
2.67%29.43M
14.72%31.42M
5.62%29.75M
-3.41%29.47M
-5.59%28.67M
-24.01%27.39M
-15.83%28.17M
-4.69%30.51M
9.37%30.36M
43.83%36.04M
9.55%33.47M
13.69%32.01M
5.48%27.76M
-0.63%25.06M
33.31%30.55M
63.23%28.15M
91.32%26.32M
114.75%25.22M
218.72%22.92M
143.43%17.25M
423.04%13.76M
308.84%11.74M
188.64%7.19M
--7.08M
--2.63M
--2.87M
--2.49M
Revenue
-6.35%27.86M
-2.01%28.87M
2.67%29.43M
14.72%31.42M
5.62%29.75M
-3.41%29.47M
-5.59%28.67M
-24.01%27.39M
-15.83%28.17M
-4.69%30.51M
9.37%30.36M
43.83%36.04M
9.55%33.47M
13.69%32.01M
5.48%27.76M
-0.63%25.06M
33.31%30.55M
63.23%28.15M
91.32%26.32M
114.75%25.22M
218.72%22.92M
143.43%17.25M
423.04%13.76M
308.84%11.74M
188.64%7.19M
--7.08M
--2.63M
--2.87M
--2.49M
Cost of revenue
-15.62%15.77M
-11.10%16.64M
-5.33%17.84M
11.05%19.55M
-6.35%18.69M
-17.88%18.72M
-18.78%18.85M
-37.87%17.61M
-26.21%19.95M
-14.73%22.80M
-0.94%23.20M
33.19%28.34M
3.57%27.04M
7.66%26.73M
0.23%23.43M
-11.96%21.27M
15.38%26.11M
47.54%24.83M
23.78%23.37M
46.40%24.16M
110.41%22.63M
70.60%16.83M
138.29%18.88M
124.82%16.51M
38.78%10.75M
--9.87M
--7.92M
--7.34M
--7.75M
Operating expenses
-2.97%44.78M
-9.40%46.50M
-13.83%45.24M
-16.97%48.28M
-29.09%46.15M
-24.36%51.33M
-30.75%52.51M
-26.87%58.15M
-15.43%65.08M
-5.53%67.86M
10.26%75.82M
15.62%79.52M
14.81%76.95M
4.18%71.83M
21.79%68.76M
24.77%68.78M
27.44%67.03M
41.11%68.95M
3.61%56.46M
50.40%55.12M
91.94%52.59M
90.46%48.86M
158.49%54.49M
86.79%36.65M
43.99%27.40M
--25.66M
--21.08M
--19.62M
--19.03M
R&D expenses
1.87%5.62M
-35.92%5.05M
-33.95%5.38M
-45.66%5.29M
-56.35%5.51M
-37.05%7.89M
-49.37%8.14M
-34.70%9.73M
-8.40%12.63M
9.51%12.53M
23.10%16.08M
10.24%14.91M
27.35%13.79M
0.30%11.44M
34.23%13.06M
68.34%13.52M
43.08%10.83M
46.58%11.41M
6.04%9.73M
32.69%8.03M
29.67%7.57M
17.42%7.78M
60.74%9.18M
8.42%6.05M
7.97%5.84M
--6.63M
--5.71M
--5.58M
--5.41M
Depreciation, depletion, and amortization
-38.56%795.00K
-37.34%881.00K
-27.32%1.01M
-21.48%1.16M
-11.37%1.29M
-2.77%1.41M
-5.12%1.39M
-2.84%1.47M
5.49%1.46M
11.23%1.45M
11.57%1.47M
14.35%1.51M
9.67%1.38M
0.00%1.30M
0.08%1.31M
-5.43%1.32M
1.28%1.26M
-34.04%1.30M
142.70%1.31M
250.00%1.40M
308.52%1.25M
429.84%1.97M
51.97%541.00K
0.00%400.00K
-23.75%305.00K
--372.00K
--356.00K
--400.00K
--400.00K
Operating profit
-3.17%-16.92M
19.35%-17.63M
33.67%-15.81M
45.18%-16.86M
55.57%-16.40M
41.48%-21.86M
47.55%-23.84M
29.24%-30.76M
15.12%-36.91M
6.20%-37.35M
-10.87%-45.45M
0.56%-43.48M
-19.22%-43.48M
2.39%-39.82M
-36.04%-41.00M
-46.19%-43.72M
-22.91%-36.48M
-29.05%-40.80M
26.01%-30.14M
-20.06%-29.91M
-46.84%-29.68M
-70.25%-31.61M
-120.78%-40.73M
-48.72%-24.91M
-22.20%-20.21M
---18.57M
---18.45M
---16.75M
---16.54M
Net non-operating interest income (expenses)
Non-operating interest income
-22.72%1.53M
-18.06%1.67M
-13.68%1.85M
-22.99%1.90M
-36.22%1.98M
-10.47%2.04M
-16.48%2.15M
-7.38%2.47M
16.99%3.10M
19.66%2.28M
219.63%2.57M
481.26%2.67M
2106.67%2.65M
1450.41%1.91M
713.13%805.00K
179.88%459.00K
7.14%120.00K
6050.00%123.00K
--99.00K
144.78%164.00K
-75.65%112.00K
-99.47%2.00K
----
-90.69%67.00K
-44.04%460.00K
--374.00K
--569.00K
--720.00K
--822.00K
Non-operating interest expense
-5.37%3.37M
-40.93%3.44M
-42.72%3.48M
-42.18%3.48M
-40.35%3.56M
70.47%5.83M
88.86%6.07M
93.68%6.01M
102.86%5.97M
63.02%3.42M
466.67%3.21M
545.11%3.10M
597.16%2.94M
386.31%2.10M
31.55%567.00K
11.60%481.00K
0.00%422.00K
0.23%431.00K
0.00%431.00K
-58.24%431.00K
-57.84%422.00K
-57.84%430.00K
-58.83%431.00K
-1.71%1.03M
-12.19%1.00M
--1.02M
--1.05M
--1.05M
--1.14M
Special income (expenses)
100.00%0.00
--0.00
--0.00
--0.00
---7.69M
--0.00
----
----
----
100.00%0.00
----
----
----
---1.37M
----
----
----
--0.00
100.00%0.00
100.00%0.00
-100.00%0.00
100.00%0.00
-131.87%-1.13M
-1362.00%-631.00K
-76.73%101.00K
---230.00K
--3.55M
--50.00K
--434.00K
Income before tax
26.91%-18.76M
24.36%-19.40M
37.19%-17.43M
46.25%-18.44M
35.48%-25.67M
33.38%-25.64M
39.78%-27.76M
21.88%-34.30M
9.13%-39.78M
6.99%-38.49M
-13.08%-46.09M
-0.39%-43.91M
-19.04%-43.78M
-0.66%-41.38M
-33.77%-40.76M
-44.97%-43.74M
-22.65%-36.78M
-28.29%-41.11M
27.96%-30.47M
-13.84%-30.17M
-45.21%-29.99M
-64.78%-32.04M
-174.96%-42.29M
-55.65%-26.50M
-25.75%-20.65M
---19.45M
---15.38M
---17.03M
---16.42M
Income tax
88.70%217.00K
2475.00%95.00K
121.98%404.00K
-31.13%104.00K
-29.01%115.00K
-103.57%-4.00K
111.63%182.00K
13.53%151.00K
-15.63%162.00K
75.00%112.00K
330.00%86.00K
38.54%133.00K
66.96%192.00K
-48.80%64.00K
--20.00K
174.29%96.00K
194.87%115.00K
--125.00K
--0.00
--35.00K
--39.00K
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--20.00K
--0.00
--0.00
Income after tax
26.39%-18.98M
23.98%-19.49M
36.16%-17.84M
46.19%-18.54M
35.45%-25.78M
33.58%-25.64M
39.50%-27.94M
21.78%-34.45M
9.16%-39.94M
6.86%-38.60M
-13.24%-46.18M
-0.47%-44.05M
-19.19%-43.97M
-0.51%-41.44M
-33.84%-40.78M
-45.12%-43.84M
-22.87%-36.89M
-28.68%-41.23M
27.96%-30.47M
-13.97%-30.21M
-45.40%-30.02M
-64.78%-32.04M
-174.60%-42.29M
-55.65%-26.50M
-25.75%-20.65M
---19.45M
---15.40M
---17.03M
---16.42M
Net income from continuous operations
26.39%-18.98M
23.98%-19.49M
36.16%-17.84M
46.19%-18.54M
35.45%-25.78M
33.58%-25.64M
39.50%-27.94M
21.78%-34.45M
9.16%-39.94M
6.86%-38.60M
-13.24%-46.18M
-0.47%-44.05M
-19.19%-43.97M
-0.51%-41.44M
-33.84%-40.78M
-45.12%-43.84M
-22.87%-36.89M
-28.68%-41.23M
27.96%-30.47M
-13.97%-30.21M
-45.40%-30.02M
-64.78%-32.04M
-174.60%-42.29M
-55.65%-26.50M
-25.75%-20.65M
---19.45M
---15.40M
---17.03M
---16.42M
Net income attributable to controlling interests
26.39%-18.98M
23.98%-19.49M
36.16%-17.84M
46.19%-18.54M
35.45%-25.78M
33.58%-25.64M
39.50%-27.94M
21.78%-34.45M
9.16%-39.94M
6.86%-38.60M
-13.24%-46.18M
-0.47%-44.05M
-19.19%-43.97M
-0.51%-41.44M
-33.84%-40.78M
-45.12%-43.84M
-22.87%-36.89M
-28.68%-41.23M
27.96%-30.47M
-260.74%-30.21M
-986.48%-30.02M
-64.77%-32.04M
-153.77%-42.29M
66.58%-8.37M
113.94%3.39M
---19.45M
---16.67M
---25.06M
---24.29M
Preferred share dividend
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
-100.00%0.00
-100.00%0.00
-95.40%362.00K
--0.00
--118.86M
--8.03M
--7.87M
Net income attributable to common shareholders
26.39%-18.98M
23.98%-19.49M
36.16%-17.84M
46.19%-18.54M
35.45%-25.78M
33.58%-25.64M
39.50%-27.94M
21.78%-34.45M
9.16%-39.94M
6.86%-38.60M
-13.24%-46.18M
-0.47%-44.05M
-19.19%-43.97M
-0.51%-41.44M
-33.84%-40.78M
-45.12%-43.84M
-22.87%-36.89M
-28.68%-41.23M
27.96%-30.47M
-260.74%-30.21M
-986.48%-30.02M
-64.77%-32.04M
-153.77%-42.29M
66.58%-8.37M
113.94%3.39M
---19.45M
---16.67M
---25.06M
---24.29M
Basic earnings per share
71.80%-1.03
85.28%-1.07
87.91%-1.00
89.51%-1.04
68.88%-3.66
36.71%-7.29
40.20%-8.30
26.19%-9.96
12.94%-11.77
8.94%-11.52
-9.19%-13.88
1.72%-13.50
-16.02%-13.52
10.82%-12.65
-29.56%-12.71
-38.45%-13.73
-10.64%-11.65
-26.27%-14.19
33.97%-9.81
-257.13%-9.92
-1037.48%-10.53
-74.16%-11.23
-168.76%-14.86
66.58%-2.78
113.94%1.12
---6.45
---5.53
---8.31
---8.06
Diluted earnings per share
71.80%-1.03
85.28%-1.07
87.91%-1.00
89.51%-1.04
68.88%-3.66
36.71%-7.29
40.20%-8.30
26.19%-9.96
12.94%-11.77
8.94%-11.52
-9.19%-13.88
1.72%-13.50
-16.02%-13.52
10.82%-12.65
-29.56%-12.71
-38.45%-13.73
-10.64%-11.65
-26.27%-14.19
33.97%-9.81
-257.13%-9.92
-1037.48%-10.53
-74.16%-11.23
-168.76%-14.86
66.58%-2.78
113.94%1.12
---6.45
---5.53
---8.31
---8.06
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read Outset Medical Inc's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing OM stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Outset Medical Inc's revenue at year end?

Outset Medical Inc reported 119.48M in revenue for fiscal year 2025, up from 113.69M in the previous year.

How much revenue did Outset Medical Inc report in the most recent quarter?

Outset Medical Inc reported 27.86M in revenue for the most recent quarter, an increase of -6.35% year over year.

What was Outset Medical Inc's net income for the year?

Outset Medical Inc posted -81.65M in net income for fiscal year 2025.

How much net income did Outset Medical Inc post in the last quarter?

Outset Medical Inc reported -18.98M in net income for the latest quarter。

What was Outset Medical Inc's annual operating profit?

Outset Medical Inc's operating income was -66.71M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.